Disclosure of Payments
In everything we do, we always start by asking ourselves "How can we create more value for people living with severe diseases?"
To do this, we work in partnership with various stakeholders including healthcare professionals, healthcare organisations and patient organisations. We are committed to operating at the highest ethical standards and therefore ensure we are transparent with these engagements and associated transfers of value.
Disclosure of payments to patient organisations in Europe
As part of our commitment to treating patients with major diseases, UCB supports a variety of programmes for those affected and their families. These include websites, information materials, events or special patient programmes, all with the goal of improving the quality of life of our patients beyond medication.
The Association of the British Pharmaceutical Industry Code requires pharmaceutical companies to make publicly available, at a national or European level, a list of patient organisations that it has engaged with to provide significant contracted services.
Please visit our global website for information on the patient groups, or companies that UCB has supported.
UK tax strategy
As per HMRC regulations, we are pleased to publish our UK tax strategy
Transfers of value to heath professionals and healthcare organisations
As a member company of EFPIA (European Federation of Pharmaceutical Industry and Associations) and the ABPI (Association of the British Pharmaceutical Industry), we are committed to meeting transparency code requirements and reporting our transfers of value to healthcare stakeholders accordingly.
The UCB Pharma transfers of value data and the methodological notes are published on the ABPI UK disclosure platform.This can be accessed via the following web address.